Marian, 1995, Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations, Eur Heart J, 16, 368, 10.1093/oxfordjournals.eurheartj.a060920
McKenna, 2002, Hypertrophic cardiomyopathy: Management, risk stratification, and prevention of sudden death, Heart, 87, 169, 10.1136/heart.87.2.169
Jääskeläinen, 1998, The cardiac betamyosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population, J Am Coll Cardiol, 32, 1709, 10.1016/S0735-1097(98)00448-3
Nishi, 1994, Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy, Biochem Biophys Res Commun, 200, 549, 10.1006/bbrc.1994.1483
Gautel, 1995, Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: A modulator of cardiac contraction?, EMBO J, 14, 1952, 10.1002/j.1460-2075.1995.tb07187.x
Schultheiss, 1990, Differential distribution of subsets of myofibrillar proteins in cardiac nonstriated and striated myofibrils, J Cell Biol, 110, 1159, 10.1083/jcb.110.4.1159
Schlender, 1991, Phosphorylation of chicken cardiac C-protein by calcium/calmodulin-dependent protein kinase II, J Biol Chem, 266, 2811, 10.1016/S0021-9258(18)49919-X
Fougerousse, 1998, Cardiac myosin binding protein C gene is specifically expressed in heart during murine and human development, Circ Res, 82, 130, 10.1161/01.RES.82.1.130
Lahiri, 1991, A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies, Nucleic Acids Res, 19, 5444, 10.1093/nar/19.19.5444
Bonne, 1995, Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy, Nat Genet, 11, 438, 10.1038/ng1295-438
Fung, 1999, An online locus-specific mutation database for familial hypertrophic cardiomyopathy, Hum Mutat, 14, 326, 10.1002/(SICI)1098-1004(199910)14:4<326::AID-HUMU8>3.0.CO;2-F
Richard, 2001, Distribution of disease genes in 102 genotyped families with hypertrophic cardiomyopathy, Circulation, 104, II
Marian, 2001, The molecular genetic basis for hypertrophic cardiomyopathy, J Mol Cell Cardiol, 33, 655, 10.1006/jmcc.2001.1340
Keller, 2002, Genetics of familial cardiomyopathies and arrhythmias, Swiss Med Wkly, 132, 401
Davies, 2000, The cardiomyopathies: An overview, Heart, 83, 469, 10.1136/heart.83.4.469
Watkins, 1992, Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy, N Engl J Med, 326, 1108, 10.1056/NEJM199204233261703
McKenna, 1998, Genes and disease expression in hypertrophic cardiomyopathy, Lancet, 352, 1162, 10.1016/S0140-6736(98)00033-6
Arad, 2002, Phenotypic diversity in hypertrophic cardiomyopathy, Hum Mol Genet, 11, 2499, 10.1093/hmg/11.20.2499
Ortlepp, 2002, Heart, 87, 270, 10.1136/heart.87.3.270
Charron, 1998, Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene, Circulation, 97, 2230, 10.1161/01.CIR.97.22.2230
Niimura, 1998, Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy, N Engl J Med, 338, 1248, 10.1056/NEJM199804303381802
Van Driest, 2004, Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy, J Am Coll Cardiol, 44, 1903, 10.1016/j.jacc.2004.07.045